$CCL: DAILY 1 YEAR VOLATILITY CHART into #Gilead says NIAID study of remdesivir as COVID-19 treatment met primary endpoint #COVID19    $AMGN $LLY $ABT $JNJ $WYNN $LVS $MGM $NCLH $AAL $UAL $DAL $MGM $MDT https://t.co/ltn998fJrr